NCT06683339Recruiting
Functional Capacity in Children with Chronic Kidney Disease
Assessment of Functional Capacity in Children with Chronic Kidney Disease
Source: ClinicalTrials.gov · Last updated 26 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of our study is to assess the functional capacity of children with chronic kidney disease using various tests.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 26 (estimated)
- First submitted
- 8 Nov 2024
- Start date
- 16 May 2022
- Primary completion date
- Dec 2024
- Lead sponsor
- Hacettepe University
- Diseases
- Chronic kidney disease
- NCT number
- NCT06683339
What you commit to
- Study type: Observational
- Planned participants: 26
- From 16 May 2022 to the primary completion date, Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having a musculoskelatal disease that may affect functional capacity measurement
Other
- Having a cognitive problem
Who the study is looking for
- Having been diagnosed with chronic kidney disease
- Being clinically stable
- Being between 6-18 years old
- Volunteering to participate in the research
Age in the registry: 6 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hacettepe University Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Recruiting |
Related publications
- Assessment of functional capacity in children with chronic kidney disease using various field tests.Pediatr Nephrol · 2026 · PMID 42113273
This page is information, not medical advice. Discuss any trial with your doctor.